Dr. Shivaani Kummar (Principal Investigator, PI), OHSU Mary Crowley Cancer Research, Montefiore Medical Center 4 1 . Tom Sellers named lead research officer at OHSU Knight Cancer Institute Read more to learn about Shivaani Kummar, MBBS's background, education, and other specialties. Shivaani Kummar, Lisa Coussens named deputy directors of OHSU Knight Shivaani KummarLisa CoussensShivaani Kummar and Lisa Coussens were named deputy directors of OHSU Knight Cancer Institute. Shivaani Kummar, Lisa Coussens named deputy directors of OHSU Knight. Hung, M.D. OHSU researchers lead innovation and passion through new discoveries, comradery of the OHSU research community and the drive to improve peoples health and well-being. Yourinsurancecompany will also be able to inform you of any copayments, coinsurance, or deductibles that will be your responsibility. SHIVAANI KUMMAR, 207RX0202X - Medical Oncology Doctors & Physicians in PORTLAND, OR. Where is Dr. Shivaani Kummar located? At the end of the day, we need to develop better treatment for cancer patients and the only way to build that is through collaboration within OHSU and with other academic centers, biotech and pharma companies., Team science can be a buzz word. The unit includes 12 treatment spaces, eight chairs, four beds, and procedure and consultation rooms. Shivaani KummarLisa CoussensShivaani Kummar and Lisa Coussens were named deputy directors of OHSU Knight Cancer Institute . He has the mindset and the clear vision to make that mindset a reality., Malhotra agrees: We speak the same language. Over the past six months, a multidisciplinary team has been coordinating patient experience, drug delivery, staffing schedules and equipment needed to support the range of clinical trials offered in the unit that span 14 different cancer disease groups. Lisa M. Coussens, M.D. The patient ratings score is an average of all responses to the question "How likely would you be to recommend this provider to your family and friends (on a scale of 0 to 10)" on our nationally-recognized NRC patient surveys. In 2021, we held our 4th Stat4Onc Symposium virtually by Stanford University. Web Browser Accessibility, New early-phase clinical trial unit in the Center for Health and Healing Building 2 on South Waterfront centralizes care for cancer patients, provides more research opportunities, OHSU expands capacity for cancer clinical trials, OHSU Knight Cancer Institute: Understanding Cancer Clinical Trials, Expanding access to experimental cancer treatments in Oregon: Q&A with Shivaani Kummar, Severe respiratory illness season means boom times for OHSU virtual immediate care, OHSU leading effort to make cancer trials more inclusive, OHSU Child Life Specialist provides life-changing care to young patient living with chronic spinal condition, Making Hepatitis C care easier when treatment seems impossible. Faculty Spotlight - Shivaani Kummar, MD, FACP | Department of Medicine boundtree continuing education; can you be charged under ucmj after discharge Learn more about clinical trials at the Knight Cancer Institute, The 13,000-square-foot early-phase research unit includes 12 treatment spaces, eight chairs, four beds, and procedure and consultation rooms. Kummars remarkable accomplishments, combined with her ability to connect with people and her clear vision for how to grow the hematology-oncology division, made her our top candidate. The Division of Hematology and Medical Oncology is headed byShivaani Kummar, M.D., FACPand composed of many sections: Kathleen Beebe Oregon Health & Science University is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. Select a country/territory to view shared publications and projects. lions led by donkeys for and against. Email: trials@ohsu.edu Call: 503-494-1080 Oregon Health & Science University. Very few institutions do it well, but OHSU truly gets it, Kummar says. Cited by. We are delighted she has chosen to join us, said Brian Druker, M.D., director of the OHSU Knight Cancer Institute. Dr. Kummar loves to spend time with her family, read, and go for long walks. Our patients in research studies can come in for their initial blood work and continue through their post treatment observation all in one place and are surrounded by a team of experts guiding them through the process.. Then we try to find what we call targets within or around cancer cells and develop drugs that can precisely hit those targets. Dr. Kummar is a cancer specialist whose focus is to bring new discoveries to the clinic, developing new treatments for cancer. SHIVAANI KUMMAR, Medical Oncology PORTLAND, OR - NPI 1053612341 Claire Yoshida, M.S.N., A.C.N.S.-B.C., A.C.H.P.N. Administrative Coordinator, Denise Hopkins Today is a global celebration of giving an opportunity to support the causes that matter the most to you. Shivaani Kummar - Professor of Medicine - Stanford - LinkedIn Its staff of physicians, nurses, pharmacists, data coordinators and clinical research coordinators are trained and experienced in caring for people participating in cancer clinical trials. shivaani kummar ohsu email - howfenalcooksthat.com Shivaani Kummar - Google Scholar shivaani kummar ohsu email - sosfoams.com Shivaani Kummar, M.D., FACP Expertise Cancer Special focus Medical Oncology and Hematology Email this page Print this page About me Dr. Kummar is a cancer specialist whose focus is to bring new discoveries to the clinic, developing new treatments for cancer. It is a privilege to be able to work in this field. This new unit allows us to centralize everything in a setting designed for a patients convenience and comfort, said Patrick McCormick, M.B.A., vice president of oncology services in the Knight Cancer Institute. Oregon Health & Science University is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. Philanthropy will allow us to expand the number of ongoing projects, including those focusing on rare tumors, as well as take on more pre- and post-doctoral students to train the next generation of cancer researchers. Home; NPI Lookup; Doctors; Medical Groups & Orgs; Taxonomy Codes; Lookup NPI Numbers from the NPI Registry . Stock and Other Ownership Interests: PathomIQ, Arxeon Therapeutics (I) Consulting or Advisory Role: Seattle Genetics, Bayer, Boehringer Ingelheim, Mundipharma EDO GmbH, Harbour BioMed, SpringWorks Therapeutics, Gilead Sciences, Mirati Therapeutics, EcoR1 Capital, Cadila Pharmaceuticals (I), Oxford BioTherapeutics. Web Browser Accessibility, An open-label, multicenter Phase I dose escalation study to characterize safety, tolerability, preliminary antitumor activity, pharmacokinetics and maximum tolerated dose of VIP152 (BAY 1251152) as monotherapy or combination therapy in subjects with advanced cancer. Shivaani KummarLisa CoussensShivaani Kummar and Lisa Coussens were named deputy directors of OHSU Knight Cancer Institute. Year; Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children. Spray Foam Equipment and Chemicals. February 17, 2023. Shivaani Kummar's research works | Institute of Cancer Research, London Patients and Methods. shivaani kummar ohsu email. Username or E-mail. L Fong, A Hotson, JD Powderly, M Sznol, RS Heist, TK Choueiri, S Kummar, A Chen, RE Parchment, RJ Kinders, J Ji, JE Tomaszewski, AF Farago, MS Taylor, RC Doebele, VW Zhu, S Kummar, AI Spira, S Kummar, M Gutierrez, ER Gardner, E Donovan, K Hwang, EJ Chung, Clinical Cancer Research 13 (18), 5411-5417. Shivaani Kummar, M.D., FACP, head of the Division of Hematology and Medical Oncology in the OHSU School of Medicine and co-director of the Knight Cancer Institute's You can also correspond with Dr. Shivaani Kummar through mail at her mailing address at 3181 Sw Sam Jackson Park Rd, , Portland, Oregon - 97239-3011 (mailing address contact number . scripps institution of oceanography graduate programs; rosemont seneca advisors website By using this website, we will assume that you agree to the terms and conditions of our privacy policy. S Kummar, A Chen, J Ji, Y Zhang, JM Reid, M Ames, L Jia, M Weil, K Do, D Wilsker, J Ji, J Zlott, T Freshwater, RJ Kinders, J Collins, AP Chen, Journal of Clinical Oncology 33 (30), 3409. Administrative Coordinator, Margaret Rogers Sign up to receive the latest news, updates and stories from the OHSU Foundation in your inbox. A husband-wife team known for specializing in cancer drug development have joined the OHSU Knight Cancer Institute. Before scheduling your appointment, we recommend you contact yourinsurancecompany to verify that the OHSU Health location or provider you plan to visit is included in your network. Title. With this new dedicated space to administer clinical trial care for patients, OHSU will continue to work to expand access to innovative clinical trials for cancer patients in Oregon and beyond.. Shivaani Kummar - PMWC Precision Medicine World Conference Shivaani Kummar Stanford University Medical Center - PMWC Precision Medicine World Conference Speaker Profile M.D., Professor of Medicine and Radiology, Stanford University; Director, Phase I Clinical Research Program-Medical Oncology; Director, Translational Oncology Program At Stanford Shivaani Kummar Biography Shivaani Kummar. (OHSU/Kristyna Wentz-Graff). Caring for them drives me to work harder to develop more effective treatments that are better tolerated. . Shivaani Kummar, M.D., FACP, is head of the Division of Hematology and Medical Oncology in the OHSU School of Medicine and co-director of the Knight Cancer Institute's Center for Experimental Therapeutics. . Shivaani Kummar: STUDY00021194: A phase 1 study of SGN-CD228A in select advanced solid tumors: . Dr. Drukers vision for the field of translational oncology is similar to our vision of how to move discoveries from laboratories towardthe clinic. Shivaani Kummar, M.D., will lead the Division of Hematology and Medical Oncology in the OHSU School of Medicine, overseeing more than 90 faculty members. These new drugs go through very rigorous testing in the laboratory and only if they meet certain criteria as promising anticancer agents, we bring them forward into the first phase of human clinical trials. You may also qualify for Phase 1 Program trials. Shivaani Kummar: STUDY00022986: An open-label, multicenter Phase I dose escalation study to characterize safety, tolerability, preliminary antitumor activity, pharmacokinetics and maximum tolerated dose of VIP152 (BAY 1251152) as monotherapy or combination therapy in subjects with advanced cancer . Shivaani Kummar | Stanford Health Care . bard college music faculty. Shivaani Kummar, MD, FACP, is head of the Division of Hematology and Medical Oncology in the OHSU School of Medicine, associate director for Clinical and Translational Research at the OHSU Knight Cancer Institute, and co-director of the Knight Cancer Institute's Center for Experimental Therapeutics. Sort by citations Sort by year Sort by title. These topic labels come from the works of this person. middlesex county community college nursing program nj OHSU is an equal opportunity affirmative action institution. Four questions with Shivaani Kummar, MD, FACP | OHSU Foundation Dr. Shivaani Kummar is an oncologist practicing in Bethesda, MD. Dr. Shivaani Kummar - Medical Oncology, Portland OR The Division of Hematology and Medical Oncology is headed by Shivaani Kummar, M.D., FACP and composed of many sections: Classical Hematology Community Oncology Hematologic Malignancies Palliative Care Portland VA Research Solid Tumor Stem Cell Transplantation Administration Section head Shivaani Kummar, M.D., FACP billing andinsurancesection of our site, Medical Oncology and Hematology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, American Board of Internal Medicine Board Certified in Internal Medicine, 1995-2005, Board Recertified in Internal Medicine, 2005-2015, Board Certified in Medical Oncology, 1998-2008, Board Recertified in Medical Oncology, 2008-2018; 2018-2028 Board Certified in Hematology, 2002-2012, Member, American Society of Clinical Oncology, Member, American Association for Cancer Research. Cited by. OHSU Knight Cancer Institute Archives - The Cancer Letter OHSU is an equal opportunity affirmative action institution. 9842741222, 9942641222, 9842724434 chinamanpaversscc@gmail.com. The field of oncology is so broad, and theres so much to be done, Kummar says. 23() 'Oregon Health & Science University Knight Cancer Institute(OHSU)' BAL0891 1 Shivaani Kummar (Principal Investigator, PI), OHSU 'Mary Crowley Cancer Research . The new unit centralizes care for patients in research studies and expands capacity to allow more people to participate in early-phase clinical trials at OHSU. Charles D. Blanke, M.D., F.A.C.P., F.A.S.C.O. Dr. Kummar specializes in the care and treatment of patients with cancer. Clinical Activity of the -Secretase Inhibitor PF-03084014 in Adults Palliative Care Administrative Assistant. Keep me signed in. Shivaani Kummar - .. - Oregon Health & Science University - ZoomInfo Having someone who understands the challenges is helpful.. (OHSU/Joe Rojas-Burke), The new unit centralizes care for patients in research studies and expands capacity to allow more people to participate in early-phase clinical trials at OHSU. (Getty Images), Communications Manager, OHSU Knight Cancer Institute, Husband-wife team from Stanford University tapped to lead two cancer programs at OHSU, OHSU leading effort to make cancer trials more inclusive, Making Hepatitis C care easier when treatment seems impossible, Pill for skin disease also curbs excessive drinking, OHSU clinical trial tests exercise for multiple sclerosis treatment. Trisha Silbernagel, RN, BSN, early-phase clinical trial unit manager, checks equipment on Aug. 23, 2021. [] , 'Nm301' Als The provider is located at 3181 Sw Sam Jackson Park Rd Portland, Or 97239 and the phone number is (503) 314-7168 Which is Dr. Shivaani Kummar specialty? DR. SHIVAANI KUMMAR NPI 1053612341 - NPI Profile Shivaani Kummar, M.D., FACP Lisa M. Coussens, M.D. She received her medical degree from Lady Hardinge Medical College and has been in practice for . Dr. Shivaani Kummar has primarily specialised in Medical Oncology for over 31 years. Equipment. , 1 Within our Center for Experimental Therapeutics, Knight Cancer Institute, we have multiple ongoing projects trying to identify new ways to target cancer. We are asking this question from time to time, and we expect to uncover a globe-full of roads to Stanford. Email: trials@ohsu.edu Call: 503-494-1080 Oregon Health & Science University. OHSU is an equal opportunity affirmative action institution. The center is designed to advance innovation efforts within the Knight Cancer Institute to discover and develop new treatments for cancer, from early phase clinical trials, to drug development. The institute is involved with more than 400 clinical trials, including 113 early-phase trials. NPI 1053612341 Dr. Shivaani Kummar in Portland - Address, Medicare Most recently, he was the director for Stanford SRI Drug Discovery and Development Program, and he trained with Nobel laureate Herb Brown at Purdue University. Dive into the research topics where Shivaani Kummar is active. Knight Cancer Institute | OHSU Knight Cancer Institute | OHSU Shivaani Kummar (OHSU) kummar@ohsu.edu Upon completing her medical degree from Lady Hardinge Medical College in New Delhi, India, Shivaani Kummar moved to the United States to train in Internal Medicine at Emory University in Atlanta, Georgia. Tom Sellers was named lead research officer at OHSU Knight Cancer Institute. The Knight Cancer Institute's Center for Experimental Therapeutics (CET) represents multidisciplinary collaborations among scientists, physicians and engineers across OHSU. OHSU HOSPITAL AND CLINICS: 380009: Provider Business Practice Location Address Details: Address: 3181 Sw Sam Jackson Park Rd, City: Portland . Division head of medical oncology Shivaani Kummar, M.D., FACP Accepting new patients Division head of radiation medicine Arthur Y. Notice of Privacy Practices Shivaani Kummar 1 2 , Apurva K Srivastava 3 , Tony Navas 3 4 , Fabiola Cecchi 5 6 , Young H Lee 5 7 , Donald P Bottaro 5 , Sook Ryun Park 1 8 , Khanh T Do 1 9 , Woondong Jeong 1 10 , Barry C Johnson 1 , Andrea R Voth 1 , Larry Rubinstein 11 , John J Wright 1 , Ralph E Parchment 3 , James H Doroshow 1 12 , Alice P Chen 13 Our ability to collaborate with academics and industries across the globe will be paramount to our success in developing new drugs for patients. Members receive periodic email communication about events, programming, news and funding opportunities. A Rajan, CA Carter, RJ Kelly, M Gutierrez, S Kummar, E Szabo, Clinical cancer research 18 (8), 2344-2351. Neoadjuvant nivolumab shows long-term benefit in NSCLC OHSU expands capacity for cancer clinical trials | OHSU News The Center for Experimental Therapeutics is co-led by Sanjay Malhotra, Ph.D., and Shivaani Kummar, M.D. Shivaani Kummar, Lisa Coussens named deputy directors of OHSU Knight Shivaani KummarLisa CoussensShivaani Kummar and Lisa Coussens were named deputy directors of OHSU Knight Cancer Institute. 2001-2022 Oregon Health & Science University. Each study answers scientific questions and tries to find better ways to prevent, diagnose or treat diseases like cancer. February 17, 2023. For help with all referral needs and questions, visit Referring Physicians. Expanding access to experimental cancer - Cancer Translated She currently practices at Oregon Health And Sciencs University Primary Care Clinic and is affiliated with Stanford Health Care. Privacy Notice: We use technologies, such as cookies, to customize content and advertising, to analyze traffic to the site and to provide a better overall experience to our users. In addition to her role as division head, Kummar will serve as co-director for a new center in the Knight Cancer Institute, theCenter for Experimental Therapeutics, which she will co-lead with Sanjay Malhotra, Ph.D. Kummar brings a wealth of experience in conducting clinical trials tailored to make early, informed decisions regarding the suitability of new drug candidates for further clinical investigation. OHSU is an equal opportunity affirmative action institution. Try restaurant style recipes at home. Together they have built a strong record of discovery, innovation and care. We have a billion reasons why you should join us. ( ) (MCI) 'BAL0891' 1 27 . 5 , IND transfer 4 . 23() 'Oregon Health . 2022 ASCO Annual Meeting - Poster Session . Articles Cited by Public access. The two will co-lead the institutes new Center for Experimental Therapeutics, uniting cutting-edge technologies with multidisciplinary preclinical and clinical investigators. In 2020, 470 Oregon residents from 28 counties consented to participate in clinical trial activities with the Knight Cancer Institute. We have a number of clinical trials investigating promising new strategies to treat cancer. Dr. Shivaani Kummar is an oncologist in Palo Alto, California and is affiliated with OHSU Hospital. Get to know some of the resear. Affiliated Hospitals Medical Group Practices Practice Location 3181 Sw Sam Jackson Park Rd Portland, Oregon 97239-3011 Map and Directions Phone: (503) 314-7168 Office Hours: Monday - Friday: 8:00 AM - 5:00 PM Saturday - Sunday: Closed Dr. Shivaani Kummar, Oncologist - FindaTopDoc Recent progress in understanding the molecular basis of cellular processes, identification of promising therapeutic targets and evolution of the regulatory landscape makes this an exciting and unprecedented time to be in the field of oncology drug development. Dive into details by clicking on the dots or, Knight Cancer Translational Oncology Program, Calculated based on number of publications stored in Pure and citations from Scopus, PQ3: Age-related immune deviation and cancer outcome, [18F]-AraG -PET imaging to evaluate immunological response to checkpoint inhibitor therapy (CKI) in patients with advanced solid tumors, Understanding the origins of rapid recurrence of pancreatic cancer after resection. In 2014, the state of Oregon supported the OHSU Knight Cancer Challenge by providing $200 million in bonding to support building cancer research and clinical trial capacity. To find better ways to treat patients. Press Release: Husband-Wife Team From Stanford - The Lund Report OHSU is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. Knight Cancer Institute | OHSU Knight Cancer Institute | OHSU Notice of Privacy Practices OHSU Foundation P.O. They say they shared an interest in cancer drug discovery and development that grew after their marriage. OHSU is an equal opportunity affirmative action institution. What are the latest results? Her research interests focus on developing novel therapies for cancer. She runs early phase clinical trials evaluating new treatments while ensuring highest standards of patient safety. Dr. Shivaani Kummar, MD, Medical Oncology Specialist - Portland, OR Shivaani Kummar: STUDY00021766: . Shivaani Kummar Director of Center for Experimental Therapeutics, Professor and Endowed Chair, Knight Cancer Institute shivaani kummar ohsu email. The units team of physicians, nurses, pharmacists, data coordinators and clinical research coordinators are trained and experienced in caring for people participating in cancer clinical trials. Administrative Coordinator, Karri Garaventa Oregon Health & Science University is dedicated to improving the health and quality of life for all Oregonians through excellence, innovation and leadership in health care, education and research. Our ability to move these projects forward and to take on new projects is limited by the available resources. Shivaani Kummar, MBBS, Portland, OR | Oncologist Office 3181 SW Sam Jackson Park Rd Portland, OR 97239 Phone+1 503-280-1223 Is this information wrong? The provider's speciality is Internal Medicine with a focus in Medical Oncology How many years of experience does Dr. Shivaani Kummar have? Across OHSU, doctors and researchers are reimagining early disease detection. Leadership The Center for Experimental Therapeutics is co-led by Sanjay Malhotra, Ph.D., and Shivaani Kummar, M.D. 2001-2022 Oregon Health & Science University. 12 Reviews). Dr. Jody Kujovich, MD - Portland, OR | Oncology - Doximity The OHSU Knight Cancer Institute has expanded its cancer research and care facilities to include a unit dedicated to serving patients participating in early-phase clinical trials. Increasing patient participation in oncology clinical trials, A Novel Artificial IntelligencePowered Method for Prediction of Early Recurrence of Prostate Cancer after Prostatectomy and Cancer Drivers, Clinical Activity of Single-Agent Cabozantinib (XL184), a Multi-receptor Tyrosine Kinase Inhibitor, in Patients with Refractory Soft-Tissue Sarcomas, Comparative Effectiveness of Larotrectinib and Entrectinib for TRK Fusion Cancer. . NPI Lookup NPI Database. Dr. Shivaani Kummar, MD | Palo Alto, CA | Oncologist | US News Doctors Knight Cancer Institute | OHSU Knight Cancer Institute | OHSU & Kummar, S. Research output: Contribution to journal Comment/debate peer-review, Research output: Contribution to journal Review article peer-review, Research output: Contribution to journal Article peer-review, Powered by Pure, Scopus & Elsevier Fingerprint Engine 2023 Elsevier B.V, We use cookies to help provide and enhance our service and tailor content. Notice of Privacy Practices Their partnership will be a perfect pairing.. Shivaani Kummar Professor Professor, Knight Cancer Institute Knight Cancer Translational Oncology Program Email kummar @ ohsu. Faculty and staff recruitment information. Education & Training Oregon Health & Science University Fellowship, Hematology and Medical Oncology, 1995 - 1997 New York Presbyterian Hospital (Columbia Campus) Residency, Internal Medicine, 1990 - 1993 Harvard Medical School Class of 1989 massachusetts vs washington state. mollie hemingway face shivaani kummar ohsu email. People | OHSU Sanjay Malhotra, Ph.D. Shivaani Kummar, M.D., FACP Patrick McCormick, M.B.A., vice president of oncology services in the Knight Cancer Institute, speaks with staff members on Aug. 23, 2021. edu h-index 8546 Citations 49 h-index 1996 2023 Research activity per year Overview Fingerprint Network Grants (5) Publications (174) Similar Profiles (1) If you made any changes in Pure these will be visible here soon.
Frank Navarro Obituary,
V8 Exhaust Crackle,
Who Is The Biggest Gangster In Liverpool,
Articles S
